Email Updates

You are here

Home

AVAC's Blog: P-Values

  • Talkin' About a Revolution: Partners in Action at the AVAC Advocacy Forum 2015

    What happens when nearly 90 advocates, largely from sub-Saharan Africa, get together for three days of strategizing, information sharing and debate?

    April 2, 2015
    General
    AVAC

  • Song of the Soul: A VMMC Advocate Puts Her Activism into Poetry at Partners Forum 2015

    The poem by Khanyisa Dunjwa evokes her motivation to merge aspects of medical male circumcision with traditional circumcision at a newly established pre-initiation camp in the Eastern Cape.

    April 2, 2015
    Voluntary Medical Male Circumcision
    Khanyisa Dunjwa

  • A New CUREiculum Launched

    With the burst of funding and scientific interest around HIV cure research in the last decade, the need for resources to increase scientific literacy around HIV cure research has become clear. The CUREiculum, launched earlier this year, is a suite of tools developed by a collaboration between community educators, advocates and research institutions.
    March 30, 2015
    Cure
    Jessica Handibode
    Karine Dubé

  • HIV Prevention on the Line: Time to Mobilize — Again

    Two meetings decades ago fundamentally changed AIDS treatment for the better. Will Vancouver 2015 be the meeting where science, rights and action get in sync and revolutionize the epidemic once again? Will Durban 2016 lead to massive mobilization for decisive action on ending the epidemic?
    March 26, 2015
    General
    AVAC

  • Support the Global Response to HIV/AIDS, Tuberculosis, and Malaria

    The United States Congress is currently considering the future budget of the President’s Emergency Plan for AIDS Relief (PEPFAR) and the Global Fund to Fight AIDS, Tuberculosis, and Malaria. Barbara Lee, a member of Congress from California, is encouraging you to reach out to your representatives and advocate for strong funding.
    March 18, 2015
    Policy
    AVAC

  • FACTS 001 Cannot Mean the End for Women: How do we PrEP for this?

    This post was written by Yvette Raphael in South Africa a few days following the announcement of the FACTS 001 microbicide gel trial results. Yvette is a 2014 AVAC Fellow working at Johns Hopkins Health and Education in South Africa. She is a leader in South Africa’s HIV prevention movement for young women.

    March 17, 2015
    Microbicides
    Yvette Raphael

  • The Dangers of False Science Reporting and Our Duty as Communicators

    In December 2009, the trial known as MDP 301 released results that the microbicide gel known as PRO 2000 had not shown efficacy among women in Zambia, South Africa, Tanzania and Uganda. These results were not unique as many efficacy trials in HIV prevention and in other arenas have shown flat results, or at times even increased risk. However, what happened after the released results was unique. Blogs and online media framed the trial as “exploitation”, resulting in skepticism about future HIV microbicide trials. Six years later, the effects of that misleading reporting can still be felt.

    March 16, 2015
    AVAC

  • Prevention on the Line Webinar Series

    AVAC is putting together a year-long series of web-based dialogues focused on HIV prevention research and implementation. Slides, audio and animations from the first set of webinars are available here. And stay tuned for details on future webinars.
    March 12, 2015
    General, Microbicides, PrEP, Treatment
    AVAC

  • Facing FACTS, and Just Getting On With It

    When I heard the FACTS results—I was sad. But microbicide researchers and advocates don't tend to linger at the pity party. We're not giving up. FACTS hurt us but it didn't break us. We all have work to do—and we're getting on with it.
    March 10, 2015
    Microbicides
    Jim Pickett

  • Women Deserve to Know About HIV Prevention Medication Too

    The US FDA approved oral PrEP. The US CDC issued guidelines for its use. PrEP has been shown to reduce the risk of acquiring HIV equally in men and women with a protection rate up to 96 percent. Yet three years later, PrEP-centric media campaigns and clinical prescriptions continue to primarily target men who have sex with men.
    March 10, 2015
    PrEP
    Anna Forbes
    Manju Chatani
    Dázon Dixon Diallo

Pages

view more